Search companies

Live

Tuesday, 17 November 2026 · 586 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Aroa Biosurgery Sets Dates for Half-Year Results and Investor Events

ARX: $0.485 -1.02% · MC: $179M

Aroa Biosurgery will discuss its half-year results at a webinar and hold an in-person Sydney investor event later this month, covering its commercial outlook, clinical evidence and growth opportunities. The announcement follows the appointment of Mark Dunwoodie as CFO, effective later this month, as James Agnew prepares to depart.

Source announcements: 2026-11-04 08:49 to 2026-11-04 08:49 Sydney time
Story updated 2026-11-04 08:51 Sydney time
SourcesAroa Biosurgery H1 FY27 Results & Investor Event
Comments